These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34990524)

  • 41. The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery.
    Routman DM; Bian SX; Diao K; Liu JL; Yu C; Ye J; Zada G; Chang EL
    Cancer Med; 2018 Mar; 7(3):757-764. PubMed ID: 29441722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
    Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
    J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
    Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuro-oncology perspective of treatment options in metastatic breast cancer.
    Soffietti R; Pellerino A; Rudà R
    Future Oncol; 2018 Jul; 14(17):1765-1774. PubMed ID: 29956562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
    Bougie E; Masson-Côté L; Mathieu D
    World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
    Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases.
    Xu Z; Lee CC; Ramesh A; Mueller AC; Schlesinger D; Cohen-Inbar O; Shih HH; Sheehan JP
    J Neurosurg; 2017 Mar; 126(3):726-734. PubMed ID: 27203149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery.
    Yang TJ; Oh JH; Folkert MR; Gupta G; Shi W; Zhang Z; Morikawa A; Seidman A; Brennan C; Yamada Y; Chan TA; Beal K
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):518-25. PubMed ID: 25194669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fractionated radiosurgery for brain metastases in 43 patients with breast carcinoma.
    Lederman G; Wronski M; Fine M
    Breast Cancer Res Treat; 2001 Jan; 65(2):145-54. PubMed ID: 11261830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone.
    Chen XJ; Xiao JP; Li XP; Jiang XS; Zhang Y; Xu YJ; Dai JR; Li YX
    Radiat Oncol; 2011 Dec; 6():175. PubMed ID: 22182786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.
    Sperduto PW; Deegan BJ; Li J; Jethwa KR; Brown PD; Lockney N; Beal K; Rana NG; Attia A; Tseng CL; Sahgal A; Shanley R; Sperduto WA; Lou E; Zahra A; Buatti JM; Yu JB; Chiang V; Molitoris JK; Masucci L; Roberge D; Shi DD; Shih HA; Olson A; Kirkpatrick JP; Braunstein S; Sneed P; Mehta MP
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):845-853. PubMed ID: 29976497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Importance of radiotherapy in stereotactic conditions (radiosurgery) in brain metastasis: experience and results of the Hôpital Pitié-Salpêtrière Group].
    Feuvret L; Germain I; Cornu P; Boisserie G; Dormont D; Hardiman C; Tep B; Faillot T; Duffau H; Simon JM; Dendale R; Delattre JY; Poisson M; Marsault C; Philippon J; Fohanno D; Baillet F; Mazeron JJ
    Cancer Radiother; 1998; 2(3):272-81. PubMed ID: 9749126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Chao ST; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    Cancer; 2017 Jun; 123(12):2283-2293. PubMed ID: 28192598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain metastasis from renal cell carcinoma.
    Bennani O; Derrey S; Langlois O; Castel H; Laquerriere A; Freger P; Proust F
    Neurochirurgie; 2014; 60(1-2):12-6. PubMed ID: 24636403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
    Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases.
    Iorio-Morin C; Mercure-Cyr R; Figueiredo G; Touchette CJ; Masson-Côté L; Mathieu D
    J Neurooncol; 2019 Dec; 145(3):551-559. PubMed ID: 31667732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
    Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
    J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinoma.
    Verma J; Jonasch E; Allen PK; Weinberg JS; Tannir N; Chang EL; Mahajan A
    Am J Clin Oncol; 2013 Dec; 36(6):620-4. PubMed ID: 22892430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.